Rank | Gene Set | Z-score |
---|---|---|
1 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.39204721 |
2 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.39204721 |
3 | NADH dehydrogenase complex assembly (GO:0010257) | 4.39204721 |
4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.21186940 |
5 | protein complex biogenesis (GO:0070271) | 4.16627236 |
6 | DNA deamination (GO:0045006) | 4.11944730 |
7 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.99722081 |
8 | pseudouridine synthesis (GO:0001522) | 3.93290749 |
9 | respiratory chain complex IV assembly (GO:0008535) | 3.89059240 |
10 | regulation of mitochondrial translation (GO:0070129) | 3.81494889 |
11 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.72150542 |
12 | ATP synthesis coupled proton transport (GO:0015986) | 3.72150542 |
13 | response to peptidoglycan (GO:0032494) | 3.69294145 |
14 | purine nucleobase biosynthetic process (GO:0009113) | 3.67417387 |
15 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.65601310 |
16 | cytochrome complex assembly (GO:0017004) | 3.60931222 |
17 | neutrophil activation involved in immune response (GO:0002283) | 3.58441442 |
18 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.51546639 |
19 | chaperone-mediated protein transport (GO:0072321) | 3.45195724 |
20 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.44460875 |
21 | electron transport chain (GO:0022900) | 3.43587345 |
22 | ubiquinone biosynthetic process (GO:0006744) | 3.42148674 |
23 | respiratory electron transport chain (GO:0022904) | 3.41725209 |
24 | purine nucleotide salvage (GO:0032261) | 3.41205813 |
25 | protein maturation by protein folding (GO:0022417) | 3.40472586 |
26 | facial nerve structural organization (GO:0021612) | 3.37310923 |
27 | lymphoid progenitor cell differentiation (GO:0002320) | 3.35818530 |
28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.35615909 |
29 | proteasome assembly (GO:0043248) | 3.33649567 |
30 | mannosylation (GO:0097502) | 3.33621385 |
31 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.32720333 |
32 | superoxide anion generation (GO:0042554) | 3.29055718 |
33 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.27476778 |
34 | nucleobase biosynthetic process (GO:0046112) | 3.27386749 |
35 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.25643483 |
36 | oxidative phosphorylation (GO:0006119) | 3.25086671 |
37 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.21940669 |
38 | termination of RNA polymerase III transcription (GO:0006386) | 3.21940669 |
39 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.19945357 |
40 | protein targeting to mitochondrion (GO:0006626) | 3.18016324 |
41 | amino sugar catabolic process (GO:0046348) | 3.16245301 |
42 | regulation of pigment cell differentiation (GO:0050932) | 3.13736252 |
43 | mature B cell differentiation (GO:0002335) | 3.11863588 |
44 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.11264052 |
45 | respiratory burst (GO:0045730) | 3.09061784 |
46 | ribosomal small subunit assembly (GO:0000028) | 3.09014614 |
47 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.07889388 |
48 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.07889388 |
49 | immunoglobulin mediated immune response (GO:0016064) | 3.07211660 |
50 | polyketide metabolic process (GO:0030638) | 3.04266488 |
51 | doxorubicin metabolic process (GO:0044598) | 3.04266488 |
52 | daunorubicin metabolic process (GO:0044597) | 3.04266488 |
53 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.02464523 |
54 | rRNA modification (GO:0000154) | 2.97474410 |
55 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.96072071 |
56 | maturation of 5.8S rRNA (GO:0000460) | 2.96028804 |
57 | signal peptide processing (GO:0006465) | 2.95167521 |
58 | mature B cell differentiation involved in immune response (GO:0002313) | 2.94668923 |
59 | ubiquinone metabolic process (GO:0006743) | 2.94031831 |
60 | mast cell activation (GO:0045576) | 2.92822110 |
61 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.91956031 |
62 | establishment of protein localization to mitochondrion (GO:0072655) | 2.91370782 |
63 | GTP biosynthetic process (GO:0006183) | 2.90444754 |
64 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.90399630 |
65 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.90141668 |
66 | base-excision repair, AP site formation (GO:0006285) | 2.89550520 |
67 | dendritic cell chemotaxis (GO:0002407) | 2.89131831 |
68 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.88602410 |
69 | developmental pigmentation (GO:0048066) | 2.87328837 |
70 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.86715486 |
71 | protein localization to mitochondrion (GO:0070585) | 2.85435659 |
72 | C-terminal protein lipidation (GO:0006501) | 2.85375254 |
73 | * dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.84906098 |
74 | omega-hydroxylase P450 pathway (GO:0097267) | 2.84343726 |
75 | mitochondrial RNA metabolic process (GO:0000959) | 2.83902542 |
76 | GPI anchor biosynthetic process (GO:0006506) | 2.82895075 |
77 | DNA double-strand break processing (GO:0000729) | 2.82818455 |
78 | cullin deneddylation (GO:0010388) | 2.81896183 |
79 | peptidyl-histidine modification (GO:0018202) | 2.81009319 |
80 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.80415574 |
81 | protein deneddylation (GO:0000338) | 2.79188138 |
82 | interferon-gamma production (GO:0032609) | 2.77442213 |
83 | positive regulation of prostaglandin secretion (GO:0032308) | 2.77045760 |
84 | ribosome assembly (GO:0042255) | 2.76744735 |
85 | deoxyribonucleotide catabolic process (GO:0009264) | 2.76295390 |
86 | deoxyribose phosphate catabolic process (GO:0046386) | 2.75926932 |
87 | neutrophil activation (GO:0042119) | 2.74717167 |
88 | mitochondrial calcium ion transport (GO:0006851) | 2.74631634 |
89 | myeloid leukocyte mediated immunity (GO:0002444) | 2.74156880 |
90 | neutrophil mediated immunity (GO:0002446) | 2.73262660 |
91 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.72835124 |
92 | cellular component biogenesis (GO:0044085) | 2.72454396 |
93 | L-methionine salvage (GO:0071267) | 2.71927625 |
94 | L-methionine biosynthetic process (GO:0071265) | 2.71927625 |
95 | amino acid salvage (GO:0043102) | 2.71927625 |
96 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.71485995 |
97 | quinone biosynthetic process (GO:1901663) | 2.70692006 |
98 | protein heterotetramerization (GO:0051290) | 2.69754542 |
99 | viral genome replication (GO:0019079) | 2.69194622 |
100 | membrane invagination (GO:0010324) | 2.69150134 |
101 | mitochondrial transport (GO:0006839) | 2.69141798 |
102 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.68952684 |
103 | negative regulation of ligase activity (GO:0051352) | 2.68952684 |
104 | ribosomal large subunit biogenesis (GO:0042273) | 2.68643467 |
105 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.68418385 |
106 | folic acid metabolic process (GO:0046655) | 2.67178871 |
107 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.66516609 |
108 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.65991406 |
109 | response to interferon-beta (GO:0035456) | 2.64786849 |
110 | transcription from mitochondrial promoter (GO:0006390) | 2.64072095 |
111 | defense response to protozoan (GO:0042832) | 2.63449541 |
112 | cranial nerve morphogenesis (GO:0021602) | 2.62876394 |
113 | hydrogen ion transmembrane transport (GO:1902600) | 2.62625127 |
114 | response to muramyl dipeptide (GO:0032495) | 2.62467909 |
115 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.62467179 |
116 | AMP metabolic process (GO:0046033) | 2.61698600 |
117 | heme biosynthetic process (GO:0006783) | 2.61679401 |
118 | leukocyte aggregation (GO:0070486) | 2.61095807 |
119 | mesonephros development (GO:0001823) | 2.61092698 |
120 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.60629336 |
121 | pattern specification involved in kidney development (GO:0061004) | 2.60382452 |
122 | kynurenine metabolic process (GO:0070189) | 2.60012684 |
123 | CENP-A containing nucleosome assembly (GO:0034080) | 2.59519184 |
124 | UTP biosynthetic process (GO:0006228) | 2.59397515 |
125 | IMP biosynthetic process (GO:0006188) | 2.59227089 |
126 | chromatin remodeling at centromere (GO:0031055) | 2.58938124 |
127 | detection of other organism (GO:0098543) | 2.58858041 |
128 | response to folic acid (GO:0051593) | 2.58746143 |
129 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.58494313 |
130 | CTP metabolic process (GO:0046036) | 2.58020383 |
131 | CTP biosynthetic process (GO:0006241) | 2.58020383 |
132 | ADP metabolic process (GO:0046031) | 2.58017477 |
133 | regulation of metalloenzyme activity (GO:0048552) | 2.57307781 |
134 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.56920605 |
135 | purine-containing compound salvage (GO:0043101) | 2.56579140 |
136 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.56430486 |
137 | response to xenobiotic stimulus (GO:0009410) | 2.56388041 |
138 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.56316505 |
139 | regulation of cilium movement (GO:0003352) | 2.56079959 |
140 | negative regulation of granulocyte differentiation (GO:0030853) | 2.56006262 |
141 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.55971958 |
142 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.55443027 |
143 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.55385451 |
144 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.55376237 |
145 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.55071411 |
146 | positive regulation of macrophage differentiation (GO:0045651) | 2.54769648 |
147 | tRNA processing (GO:0008033) | 2.54750917 |
148 | myeloid dendritic cell activation (GO:0001773) | 2.54329845 |
149 | glutathione derivative metabolic process (GO:1901685) | 2.53571095 |
150 | glutathione derivative biosynthetic process (GO:1901687) | 2.53571095 |
151 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.53009883 |
152 | dendritic cell migration (GO:0036336) | 2.52975699 |
153 | telomere maintenance via recombination (GO:0000722) | 2.50948362 |
154 | negative regulation of myotube differentiation (GO:0010832) | 2.49659743 |
155 | cotranslational protein targeting to membrane (GO:0006613) | 2.49597490 |
156 | regulation of growth of symbiont in host (GO:0044126) | 2.48912328 |
157 | negative regulation of growth of symbiont in host (GO:0044130) | 2.48912328 |
158 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.48912328 |
159 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.48912328 |
160 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.48703700 |
161 | viral transcription (GO:0019083) | 2.48248517 |
162 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.48023206 |
163 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.48023206 |
164 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.47882579 |
165 | granulocyte activation (GO:0036230) | 2.47780413 |
166 | detection of bacterium (GO:0016045) | 2.47591884 |
167 | platelet dense granule organization (GO:0060155) | 2.47445927 |
168 | positive regulation of antigen processing and presentation (GO:0002579) | 2.47193802 |
169 | protein targeting to ER (GO:0045047) | 2.46639557 |
170 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.46224694 |
171 | sphingoid metabolic process (GO:0046519) | 2.45736327 |
172 | postsynaptic membrane organization (GO:0001941) | 2.44036536 |
173 | positive regulation of T cell migration (GO:2000406) | 2.43865047 |
174 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.43134606 |
175 | regulation of antigen processing and presentation (GO:0002577) | 2.40902733 |
176 | regulation of RIG-I signaling pathway (GO:0039535) | 2.40295628 |
177 | regulation of T cell migration (GO:2000404) | 2.40070200 |
178 | ribosomal small subunit biogenesis (GO:0042274) | 2.38204562 |
179 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.38005723 |
180 | cellular response to exogenous dsRNA (GO:0071360) | 2.37162001 |
181 | response to protozoan (GO:0001562) | 2.36442155 |
182 | protein localization to endoplasmic reticulum (GO:0070972) | 2.36108784 |
183 | generation of neurons (GO:0048699) | 2.34287594 |
184 | negative regulation of metanephros development (GO:0072217) | 2.33825551 |
185 | GDP-mannose metabolic process (GO:0019673) | 2.33567268 |
186 | C-terminal protein amino acid modification (GO:0018410) | 2.32992855 |
187 | presynaptic membrane assembly (GO:0097105) | 2.32154032 |
188 | cellular response to type I interferon (GO:0071357) | 2.32095969 |
189 | type I interferon signaling pathway (GO:0060337) | 2.32095969 |
190 | B cell mediated immunity (GO:0019724) | 2.31722432 |
191 | N-acetylneuraminate metabolic process (GO:0006054) | 2.31700655 |
192 | cellular response to interferon-beta (GO:0035458) | 2.31308671 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.39561441 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.89453003 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.81339330 |
4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.70887202 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.41492480 |
6 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.38518791 |
7 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.16232001 |
8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.10078835 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.06985954 |
10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.04835491 |
11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.99466332 |
12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.97381012 |
13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.90971789 |
14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.70671242 |
15 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.70134904 |
16 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.64256970 |
17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.60409628 |
18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.59740588 |
19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.59331488 |
20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.57101272 |
21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.52036685 |
22 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.50718660 |
23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42964349 |
24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.42369092 |
25 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.41178392 |
26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.40530264 |
27 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.37482842 |
28 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.36867157 |
29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35364129 |
30 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.32947684 |
31 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.29511400 |
32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.24074984 |
33 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20577469 |
34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.16799838 |
35 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.16382900 |
36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.15936497 |
37 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.13684121 |
38 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11861036 |
39 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.09357399 |
40 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.05291693 |
41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.04694235 |
42 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.03907532 |
43 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.01170065 |
44 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.00324425 |
45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92462267 |
46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.88818953 |
47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.88510497 |
48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.86105882 |
49 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.85334130 |
50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.82899508 |
51 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79521127 |
52 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.76163296 |
53 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.71286842 |
54 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.70397023 |
55 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.68361452 |
56 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68262637 |
57 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.66991924 |
58 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.66451424 |
59 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.66369053 |
60 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.66329594 |
61 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65286234 |
62 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.65206963 |
63 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.61915611 |
64 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.61462938 |
65 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.59803656 |
66 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.59381126 |
67 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.57289128 |
68 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.53477574 |
69 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.51768782 |
70 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.51306640 |
71 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.49875349 |
72 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48888358 |
73 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.48163606 |
74 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47894513 |
75 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45924156 |
76 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45314065 |
77 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.44397047 |
78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44193353 |
79 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.42879151 |
80 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.41971763 |
81 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.41896384 |
82 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.39877944 |
83 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39453129 |
84 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36892615 |
85 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35371411 |
86 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.32035042 |
87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31646576 |
88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.28805146 |
89 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.28641146 |
90 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.28270214 |
91 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.28061634 |
92 | * MYB_26560356_Chip-Seq_TH2_Human | 1.26773185 |
93 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.25043746 |
94 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.21577219 |
95 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.21181580 |
96 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.20913543 |
97 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20774181 |
98 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.19727050 |
99 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18427565 |
100 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.17732572 |
101 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.15966574 |
102 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15680594 |
103 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.15615201 |
104 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.14794703 |
105 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.14218399 |
106 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13733312 |
107 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.13329927 |
108 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.12471066 |
109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11951387 |
110 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.11935197 |
111 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11856493 |
112 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11772318 |
113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11626602 |
114 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.11524852 |
115 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.11472144 |
116 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.09391522 |
117 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08845927 |
118 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.08727433 |
119 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08674704 |
120 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.08489837 |
121 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.08001694 |
122 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06612064 |
123 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.06343428 |
124 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.06208075 |
125 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04966112 |
126 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04319092 |
127 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.03060319 |
128 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.01260511 |
129 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01259330 |
130 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99462272 |
131 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98696056 |
132 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97615652 |
133 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97584478 |
134 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95687269 |
135 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95385908 |
136 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.95221927 |
137 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.94140717 |
138 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93994067 |
139 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93126592 |
140 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.92926805 |
141 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92709434 |
142 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.92278753 |
143 | MYB_26560356_Chip-Seq_TH1_Human | 0.92193976 |
144 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.91956225 |
145 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91469794 |
146 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91045967 |
147 | * EWS_26573619_Chip-Seq_HEK293_Human | 0.90944707 |
148 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90887428 |
149 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.90780820 |
150 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.90558731 |
151 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.89557039 |
152 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.89374846 |
153 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.89198413 |
154 | AR_20517297_ChIP-Seq_VCAP_Human | 0.88926953 |
155 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88716842 |
156 | VDR_22108803_ChIP-Seq_LS180_Human | 0.88328778 |
157 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86748500 |
158 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.84538766 |
159 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.83507566 |
160 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.83031906 |
161 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.82408513 |
162 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.81551283 |
163 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.78691681 |
164 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.75296951 |
165 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.75143793 |
166 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.73629810 |
167 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.70148109 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003806_abnormal_nucleotide_metabolis | 5.31321766 |
2 | MP0009697_abnormal_copulation | 3.78627285 |
3 | MP0002837_dystrophic_cardiac_calcinosis | 3.46021140 |
4 | MP0009379_abnormal_foot_pigmentation | 3.38612285 |
5 | MP0003136_yellow_coat_color | 3.34762243 |
6 | MP0003724_increased_susceptibility_to | 3.14484036 |
7 | MP0001835_abnormal_antigen_presentation | 3.08777015 |
8 | MP0006292_abnormal_olfactory_placode | 3.02178915 |
9 | MP0001188_hyperpigmentation | 3.01110246 |
10 | MP0005174_abnormal_tail_pigmentation | 2.96415482 |
11 | MP0005409_darkened_coat_color | 2.88232549 |
12 | MP0009785_altered_susceptibility_to | 2.83221538 |
13 | MP0006036_abnormal_mitochondrial_physio | 2.82295375 |
14 | MP0000015_abnormal_ear_pigmentation | 2.81034365 |
15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.75747113 |
16 | MP0002148_abnormal_hypersensitivity_rea | 2.66694209 |
17 | MP0008260_abnormal_autophagy | 2.61863744 |
18 | MP0004381_abnormal_hair_follicle | 2.58255460 |
19 | MP0005671_abnormal_response_to | 2.51582343 |
20 | MP0001764_abnormal_homeostasis | 2.47957745 |
21 | MP0003718_maternal_effect | 2.44903285 |
22 | MP0010094_abnormal_chromosome_stability | 2.41517848 |
23 | MP0001986_abnormal_taste_sensitivity | 2.31784765 |
24 | MP0003195_calcinosis | 2.28898111 |
25 | MP0005075_abnormal_melanosome_morpholog | 2.27765561 |
26 | MP0003436_decreased_susceptibility_to | 2.26538897 |
27 | MP0005025_abnormal_response_to | 2.23643128 |
28 | MP0005000_abnormal_immune_tolerance | 2.23510758 |
29 | MP0002419_abnormal_innate_immunity | 2.18249451 |
30 | MP0003763_abnormal_thymus_physiology | 2.14956247 |
31 | MP0003656_abnormal_erythrocyte_physiolo | 2.13843824 |
32 | MP0006035_abnormal_mitochondrial_morpho | 2.11416444 |
33 | MP0000372_irregular_coat_pigmentation | 2.07073385 |
34 | MP0000685_abnormal_immune_system | 2.04102566 |
35 | MP0002723_abnormal_immune_serum | 1.88939399 |
36 | MP0002452_abnormal_antigen_presenting | 1.87469249 |
37 | MP0009333_abnormal_splenocyte_physiolog | 1.87378487 |
38 | MP0001800_abnormal_humoral_immune | 1.87352651 |
39 | MP0005646_abnormal_pituitary_gland | 1.84844016 |
40 | MP0002420_abnormal_adaptive_immunity | 1.83809094 |
41 | MP0001819_abnormal_immune_cell | 1.82650740 |
42 | MP0004957_abnormal_blastocyst_morpholog | 1.82543132 |
43 | MP0008057_abnormal_DNA_replication | 1.82343523 |
44 | MP0005387_immune_system_phenotype | 1.78829946 |
45 | MP0001790_abnormal_immune_system | 1.78829946 |
46 | MP0008007_abnormal_cellular_replicative | 1.74284557 |
47 | MP0002160_abnormal_reproductive_system | 1.72989263 |
48 | MP0002095_abnormal_skin_pigmentation | 1.71976585 |
49 | MP0000358_abnormal_cell_content/ | 1.63657374 |
50 | MP0002277_abnormal_respiratory_mucosa | 1.62846074 |
51 | MP0002876_abnormal_thyroid_physiology | 1.59770961 |
52 | MP0000490_abnormal_crypts_of | 1.57520941 |
53 | MP0000681_abnormal_thyroid_gland | 1.56090353 |
54 | MP0001529_abnormal_vocalization | 1.54659611 |
55 | MP0002139_abnormal_hepatobiliary_system | 1.48743202 |
56 | MP0005464_abnormal_platelet_physiology | 1.46560430 |
57 | MP0000465_gastrointestinal_hemorrhage | 1.46503778 |
58 | MP0005410_abnormal_fertilization | 1.45593945 |
59 | MP0006082_CNS_inflammation | 1.43065270 |
60 | MP0008932_abnormal_embryonic_tissue | 1.42064582 |
61 | MP0002132_abnormal_respiratory_system | 1.41849525 |
62 | MP0009840_abnormal_foam_cell | 1.40785278 |
63 | MP0001545_abnormal_hematopoietic_system | 1.40118251 |
64 | MP0003111_abnormal_nucleus_morphology | 1.40079404 |
65 | MP0000716_abnormal_immune_system | 1.39613571 |
66 | MP0001853_heart_inflammation | 1.38847000 |
67 | MP0001727_abnormal_embryo_implantation | 1.38121800 |
68 | MP0002405_respiratory_system_inflammati | 1.38050646 |
69 | MP0003075_altered_response_to | 1.37362796 |
70 | MP0002398_abnormal_bone_marrow | 1.36363013 |
71 | MP0002877_abnormal_melanocyte_morpholog | 1.35546124 |
72 | MP0000566_synostosis | 1.34418488 |
73 | MP0002933_joint_inflammation | 1.31448999 |
74 | MP0005636_abnormal_mineral_homeostasis | 1.31441186 |
75 | MP0002638_abnormal_pupillary_reflex | 1.29109892 |
76 | MP0005165_increased_susceptibility_to | 1.27273889 |
77 | MP0003077_abnormal_cell_cycle | 1.24469869 |
78 | MP0002396_abnormal_hematopoietic_system | 1.22243074 |
79 | MP0003303_peritoneal_inflammation | 1.20924962 |
80 | MP0008789_abnormal_olfactory_epithelium | 1.20147377 |
81 | MP0001845_abnormal_inflammatory_respons | 1.18861124 |
82 | MP0004043_abnormal_pH_regulation | 1.18586348 |
83 | MP0010155_abnormal_intestine_physiology | 1.17774722 |
84 | MP0003646_muscle_fatigue | 1.17643605 |
85 | MP0001881_abnormal_mammary_gland | 1.16694920 |
86 | MP0002102_abnormal_ear_morphology | 1.16188371 |
87 | MP0000689_abnormal_spleen_morphology | 1.15761775 |
88 | MP0001873_stomach_inflammation | 1.15059291 |
89 | MP0010307_abnormal_tumor_latency | 1.14601736 |
90 | MP0000858_altered_metastatic_potential | 1.14469552 |
91 | MP0002006_tumorigenesis | 1.13567045 |
92 | MP0002166_altered_tumor_susceptibility | 1.13377902 |
93 | MP0002429_abnormal_blood_cell | 1.12298110 |
94 | MP0001533_abnormal_skeleton_physiology | 1.11821823 |
95 | MP0000613_abnormal_salivary_gland | 1.09854021 |
96 | MP0002254_reproductive_system_inflammat | 1.09724416 |
97 | MP0002009_preneoplasia | 1.09529370 |
98 | MP0002722_abnormal_immune_system | 1.08749364 |
99 | MP0005171_absent_coat_pigmentation | 1.07630322 |
100 | MP0005501_abnormal_skin_physiology | 1.05812864 |
101 | MP0008469_abnormal_protein_level | 1.01887828 |
102 | MP0002177_abnormal_outer_ear | 1.01707864 |
103 | MP0003172_abnormal_lysosome_physiology | 1.01659994 |
104 | MP0005084_abnormal_gallbladder_morpholo | 1.01361870 |
105 | MP0005395_other_phenotype | 1.01280130 |
106 | MP0005647_abnormal_sex_gland | 1.00459584 |
107 | MP0005389_reproductive_system_phenotype | 0.99631899 |
108 | MP0005332_abnormal_amino_acid | 0.99118428 |
109 | MP0009764_decreased_sensitivity_to | 0.98024601 |
110 | MP0005058_abnormal_lysosome_morphology | 0.97817655 |
111 | MP0004782_abnormal_surfactant_physiolog | 0.97141088 |
112 | MP0000678_abnormal_parathyroid_gland | 0.95997748 |
113 | MP0002796_impaired_skin_barrier | 0.95968312 |
114 | MP0005379_endocrine/exocrine_gland_phen | 0.95597633 |
115 | MP0001984_abnormal_olfaction | 0.93226959 |
116 | MP0002938_white_spotting | 0.92338202 |
117 | MP0001542_abnormal_bone_strength | 0.91580267 |
118 | MP0008058_abnormal_DNA_repair | 0.91029329 |
119 | MP0002751_abnormal_autonomic_nervous | 0.89798821 |
120 | MP0000049_abnormal_middle_ear | 0.89187640 |
121 | MP0005257_abnormal_intraocular_pressure | 0.88168637 |
122 | MP0005310_abnormal_salivary_gland | 0.88097681 |
123 | MP0002998_abnormal_bone_remodeling | 0.87813067 |
124 | MP0002090_abnormal_vision | 0.87574858 |
125 | MP0005365_abnormal_bile_salt | 0.86782200 |
126 | MP0008004_abnormal_stomach_pH | 0.85513450 |
127 | MP0000313_abnormal_cell_death | 0.84796016 |
128 | MP0002163_abnormal_gland_morphology | 0.84562501 |
129 | MP0004133_heterotaxia | 0.84204125 |
130 | MP0003866_abnormal_defecation | 0.83054304 |
131 | MP0005376_homeostasis/metabolism_phenot | 0.83033047 |
132 | MP0000604_amyloidosis | 0.82255875 |
133 | MP0003011_delayed_dark_adaptation | 0.81833292 |
134 | MP0005319_abnormal_enzyme/_coenzyme | 0.81647001 |
135 | MP0001663_abnormal_digestive_system | 0.81517802 |
136 | MP0001346_abnormal_lacrimal_gland | 0.80987246 |
137 | MP0003786_premature_aging | 0.80853652 |
138 | MP0001186_pigmentation_phenotype | 0.80118379 |
139 | MP0001905_abnormal_dopamine_level | 0.79924281 |
140 | MP0003880_abnormal_central_pattern | 0.79832038 |
141 | MP0005330_cardiomyopathy | 0.77835624 |
142 | MP0005645_abnormal_hypothalamus_physiol | 0.77231623 |
143 | MP0009278_abnormal_bone_marrow | 0.77092771 |
144 | MP0000343_altered_response_to | 0.76981192 |
145 | MP0003315_abnormal_perineum_morphology | 0.76222711 |
146 | MP0005266_abnormal_metabolism | 0.75730901 |
147 | MP0003186_abnormal_redox_activity | 0.73698882 |
148 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71537304 |
149 | MP0004147_increased_porphyrin_level | 0.71482125 |
150 | MP0001919_abnormal_reproductive_system | 0.70998517 |
151 | MP0008873_increased_physiological_sensi | 0.70883306 |
152 | MP0003693_abnormal_embryo_hatching | 0.70513586 |
153 | MP0003183_abnormal_peptide_metabolism | 0.70360425 |
154 | MP0003828_pulmonary_edema | 0.70277457 |
155 | MP0000703_abnormal_thymus_morphology | 0.70125938 |
156 | MP0002075_abnormal_coat/hair_pigmentati | 0.69744675 |
157 | MP0001485_abnormal_pinna_reflex | 0.69697842 |
158 | MP0005220_abnormal_exocrine_pancreas | 0.68101125 |
159 | MP0001929_abnormal_gametogenesis | 0.67650742 |
160 | MP0010386_abnormal_urinary_bladder | 0.67402925 |
161 | MP0003448_altered_tumor_morphology | 0.66346607 |
162 | MP0001851_eye_inflammation | 0.65812194 |
163 | MP0005397_hematopoietic_system_phenotyp | 0.65768685 |
164 | MP0000427_abnormal_hair_cycle | 0.63694304 |
165 | MP0002019_abnormal_tumor_incidence | 0.63427322 |
166 | MP0000647_abnormal_sebaceous_gland | 0.61871422 |
167 | MP0001191_abnormal_skin_condition | 0.61034468 |
168 | MP0000627_abnormal_mammary_gland | 0.58433012 |
169 | MP0006072_abnormal_retinal_apoptosis | 0.58239224 |
170 | MP0004215_abnormal_myocardial_fiber | 0.57822172 |
171 | MP0008872_abnormal_physiological_respon | 0.56908738 |
172 | MP0000598_abnormal_liver_morphology | 0.55743716 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Acute necrotizing encephalopathy (HP:0006965) | 4.45175756 |
2 | * Type I transferrin isoform profile (HP:0003642) | 4.41484842 |
3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.31888600 |
4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.31888600 |
5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.31888600 |
6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.27468826 |
7 | Acute encephalopathy (HP:0006846) | 4.21630320 |
8 | Mitochondrial inheritance (HP:0001427) | 4.11400524 |
9 | Recurrent abscess formation (HP:0002722) | 4.03493698 |
10 | Increased CSF lactate (HP:0002490) | 3.95829340 |
11 | Progressive macrocephaly (HP:0004481) | 3.54084850 |
12 | Chronic obstructive pulmonary disease (HP:0006510) | 3.47009890 |
13 | Obstructive lung disease (HP:0006536) | 3.47009890 |
14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.40560423 |
15 | Hyperglycinemia (HP:0002154) | 3.39482999 |
16 | Hypothermia (HP:0002045) | 3.37715020 |
17 | Recurrent bacterial skin infections (HP:0005406) | 3.31502376 |
18 | * Reduced antithrombin III activity (HP:0001976) | 3.29338618 |
19 | Eczematoid dermatitis (HP:0000976) | 3.26608138 |
20 | Myositis (HP:0100614) | 3.25220306 |
21 | Stomatitis (HP:0010280) | 3.14792630 |
22 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.14595278 |
23 | Mediastinal lymphadenopathy (HP:0100721) | 3.11928766 |
24 | * Abnormal protein glycosylation (HP:0012346) | 3.07800256 |
25 | * Abnormal glycosylation (HP:0012345) | 3.07800256 |
26 | * Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.07800256 |
27 | * Abnormal protein N-linked glycosylation (HP:0012347) | 3.07800256 |
28 | Meningitis (HP:0001287) | 3.06902952 |
29 | Cerebral edema (HP:0002181) | 2.98960259 |
30 | Thyroid-stimulating hormone excess (HP:0002925) | 2.92956983 |
31 | Respiratory failure (HP:0002878) | 2.92349286 |
32 | Lactic acidosis (HP:0003128) | 2.90889447 |
33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.89292784 |
34 | Increased serum lactate (HP:0002151) | 2.89062226 |
35 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.87534402 |
36 | Dicarboxylic aciduria (HP:0003215) | 2.87534402 |
37 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.82543599 |
38 | Increased cerebral lipofuscin (HP:0011813) | 2.82492721 |
39 | Vacuolated lymphocytes (HP:0001922) | 2.80704930 |
40 | Renal Fanconi syndrome (HP:0001994) | 2.79921255 |
41 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.77391890 |
42 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.77391890 |
43 | Retrobulbar optic neuritis (HP:0100654) | 2.77377351 |
44 | Optic neuritis (HP:0100653) | 2.77377351 |
45 | Exertional dyspnea (HP:0002875) | 2.77141513 |
46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.73190178 |
47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.73190178 |
48 | Increased hepatocellular lipid droplets (HP:0006565) | 2.71861578 |
49 | Abnormality of the prostate (HP:0008775) | 2.68504247 |
50 | Methylmalonic aciduria (HP:0012120) | 2.65665627 |
51 | Recurrent skin infections (HP:0001581) | 2.63787929 |
52 | Aplastic anemia (HP:0001915) | 2.63355474 |
53 | Abnormality of macrophages (HP:0004311) | 2.62869114 |
54 | Reticulocytopenia (HP:0001896) | 2.62617829 |
55 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.62140282 |
56 | Abnormality of alanine metabolism (HP:0010916) | 2.62140282 |
57 | Hyperalaninemia (HP:0003348) | 2.62140282 |
58 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.61435920 |
59 | Generalized aminoaciduria (HP:0002909) | 2.60501224 |
60 | Multiple enchondromatosis (HP:0005701) | 2.58132401 |
61 | Lethargy (HP:0001254) | 2.56939026 |
62 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.55565218 |
63 | Orchitis (HP:0100796) | 2.55342001 |
64 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.51119480 |
65 | 3-Methylglutaconic aciduria (HP:0003535) | 2.48733130 |
66 | Dry hair (HP:0011359) | 2.48526183 |
67 | Nonprogressive disorder (HP:0003680) | 2.46344388 |
68 | Petechiae (HP:0000967) | 2.45283563 |
69 | Abnormal number of erythroid precursors (HP:0012131) | 2.44757699 |
70 | Methylmalonic acidemia (HP:0002912) | 2.44423813 |
71 | CNS demyelination (HP:0007305) | 2.43457585 |
72 | Parakeratosis (HP:0001036) | 2.43255093 |
73 | Increased serum pyruvate (HP:0003542) | 2.39825533 |
74 | Nausea (HP:0002018) | 2.39230505 |
75 | Opisthotonus (HP:0002179) | 2.38975139 |
76 | Increased muscle lipid content (HP:0009058) | 2.38223276 |
77 | Hyperammonemia (HP:0001987) | 2.36502065 |
78 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.35801929 |
79 | Abnormality of magnesium homeostasis (HP:0004921) | 2.34263284 |
80 | True hermaphroditism (HP:0010459) | 2.32726254 |
81 | Recurrent fungal infections (HP:0002841) | 2.31499584 |
82 | Loss of speech (HP:0002371) | 2.30703302 |
83 | Increased intramyocellular lipid droplets (HP:0012240) | 2.30056969 |
84 | Cheilitis (HP:0100825) | 2.28458371 |
85 | Mutism (HP:0002300) | 2.28394263 |
86 | Vasculitis (HP:0002633) | 2.26169869 |
87 | Abnormality of serum amino acid levels (HP:0003112) | 2.26070237 |
88 | Severe visual impairment (HP:0001141) | 2.24884947 |
89 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.24210034 |
90 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.23750986 |
91 | Microretrognathia (HP:0000308) | 2.23471621 |
92 | Dysostosis multiplex (HP:0000943) | 2.23074978 |
93 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.23023742 |
94 | Abnormality of glycine metabolism (HP:0010895) | 2.23023742 |
95 | Lipid accumulation in hepatocytes (HP:0006561) | 2.22734981 |
96 | Hemoptysis (HP:0002105) | 2.22196091 |
97 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.21648046 |
98 | Chromsome breakage (HP:0040012) | 2.21547001 |
99 | Testicular atrophy (HP:0000029) | 2.18567059 |
100 | IgM deficiency (HP:0002850) | 2.17857239 |
101 | Tubulointerstitial nephritis (HP:0001970) | 2.17520259 |
102 | Abnormal sex determination (HP:0012244) | 2.16425446 |
103 | Sex reversal (HP:0012245) | 2.16425446 |
104 | Medial flaring of the eyebrow (HP:0010747) | 2.16341838 |
105 | Basal ganglia calcification (HP:0002135) | 2.16104799 |
106 | Prolonged bleeding time (HP:0003010) | 2.15416446 |
107 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.14636845 |
108 | Hypoplasia of the fovea (HP:0007750) | 2.14636845 |
109 | Exercise intolerance (HP:0003546) | 2.14256359 |
110 | Hepatocellular necrosis (HP:0001404) | 2.13337512 |
111 | Clubbing of toes (HP:0100760) | 2.12856133 |
112 | Abnormality of the axillary hair (HP:0100134) | 2.12804468 |
113 | Abnormality of secondary sexual hair (HP:0009888) | 2.12804468 |
114 | Patchy hypopigmentation of hair (HP:0011365) | 2.12320091 |
115 | Attenuation of retinal blood vessels (HP:0007843) | 2.11980506 |
116 | Ketosis (HP:0001946) | 2.09704716 |
117 | Recurrent pneumonia (HP:0006532) | 2.09394110 |
118 | Congenital primary aphakia (HP:0007707) | 2.08649776 |
119 | Agammaglobulinemia (HP:0004432) | 2.08366845 |
120 | Chronic otitis media (HP:0000389) | 2.06105211 |
121 | Microvesicular hepatic steatosis (HP:0001414) | 2.04703900 |
122 | Abnormality of renal resorption (HP:0011038) | 2.02539438 |
123 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01022308 |
124 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01022308 |
125 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01022308 |
126 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.00754955 |
127 | Pulmonary fibrosis (HP:0002206) | 2.00466145 |
128 | Type 2 muscle fiber atrophy (HP:0003554) | 2.00274283 |
129 | Pulmonary infiltrates (HP:0002113) | 1.98639930 |
130 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.98066808 |
131 | Abnormality of the preputium (HP:0100587) | 1.97846481 |
132 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.97549551 |
133 | White forelock (HP:0002211) | 1.96404265 |
134 | Abnormality of glycolysis (HP:0004366) | 1.95192444 |
135 | Metaphyseal dysplasia (HP:0100255) | 1.94687482 |
136 | Gait imbalance (HP:0002141) | 1.93008615 |
137 | Thrombocytosis (HP:0001894) | 1.92585545 |
138 | Progressive neurologic deterioration (HP:0002344) | 1.90965925 |
139 | Nephrogenic diabetes insipidus (HP:0009806) | 1.88659673 |
140 | Epistaxis (HP:0000421) | 1.88400244 |
141 | Hyperglycinuria (HP:0003108) | 1.86965237 |
142 | Optic disc pallor (HP:0000543) | 1.85770051 |
143 | B lymphocytopenia (HP:0010976) | 1.83137088 |
144 | Muscle fiber atrophy (HP:0100295) | 1.82939499 |
145 | Gliosis (HP:0002171) | 1.82803268 |
146 | Abnormality of dental color (HP:0011073) | 1.82387809 |
147 | Prostate neoplasm (HP:0100787) | 1.82107014 |
148 | Mucopolysacchariduria (HP:0008155) | 1.81589726 |
149 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81589726 |
150 | Increased IgM level (HP:0003496) | 1.81351817 |
151 | Pancytopenia (HP:0001876) | 1.81265532 |
152 | Metabolic acidosis (HP:0001942) | 1.81108557 |
153 | Encephalitis (HP:0002383) | 1.80961673 |
154 | Vomiting (HP:0002013) | 1.80403091 |
155 | Hypoplasia of the uterus (HP:0000013) | 1.80253484 |
156 | Beaking of vertebral bodies (HP:0004568) | 1.79680861 |
157 | Prolonged neonatal jaundice (HP:0006579) | 1.78990743 |
158 | Recurrent lower respiratory tract infections (HP:0002783) | 1.78807536 |
159 | Abnormality of T cell physiology (HP:0011840) | 1.78785229 |
160 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.78722483 |
161 | Meckel diverticulum (HP:0002245) | 1.78614309 |
162 | Poor head control (HP:0002421) | 1.78545801 |
163 | Death in infancy (HP:0001522) | 1.77549312 |
164 | Abnormality of DNA repair (HP:0003254) | 1.77430981 |
165 | Renal tubular dysfunction (HP:0000124) | 1.77082513 |
166 | Hepatic necrosis (HP:0002605) | 1.76618971 |
167 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.76540059 |
168 | Pancreatic fibrosis (HP:0100732) | 1.76136063 |
169 | Abnormality of B cell number (HP:0010975) | 1.75824710 |
170 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.74816349 |
171 | Abnormality of the fovea (HP:0000493) | 1.73965617 |
172 | Abnormality of the anterior horn cell (HP:0006802) | 1.73732915 |
173 | Degeneration of anterior horn cells (HP:0002398) | 1.73732915 |
174 | Albinism (HP:0001022) | 1.73134998 |
175 | Ocular albinism (HP:0001107) | 1.72385144 |
176 | Panhypogammaglobulinemia (HP:0003139) | 1.71931524 |
177 | Pallor (HP:0000980) | 1.71914866 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TNIK | 5.44121690 |
2 | VRK2 | 4.56794617 |
3 | EIF2AK3 | 3.71006092 |
4 | BUB1 | 3.33371540 |
5 | NLK | 3.22225091 |
6 | SCYL2 | 3.14779348 |
7 | NME2 | 2.99321316 |
8 | IRAK4 | 2.99132833 |
9 | STK16 | 2.90191236 |
10 | CASK | 2.72429706 |
11 | MKNK2 | 2.66295257 |
12 | IRAK3 | 2.58781278 |
13 | BCKDK | 2.54889783 |
14 | MUSK | 2.33724293 |
15 | TEC | 2.14252004 |
16 | BLK | 2.08839911 |
17 | NUAK1 | 1.99890169 |
18 | TLK1 | 1.98900733 |
19 | TXK | 1.98576666 |
20 | EIF2AK1 | 1.88755721 |
21 | MAP3K14 | 1.82362459 |
22 | CSNK1G3 | 1.81758395 |
23 | EIF2AK2 | 1.78520101 |
24 | PIM2 | 1.78253076 |
25 | KIT | 1.76288807 |
26 | MKNK1 | 1.61671706 |
27 | CSNK1A1L | 1.59408587 |
28 | CLK1 | 1.59288831 |
29 | FES | 1.55440162 |
30 | ABL2 | 1.50189706 |
31 | TAF1 | 1.46837912 |
32 | BTK | 1.42266237 |
33 | YES1 | 1.41221017 |
34 | TTK | 1.40509959 |
35 | CAMKK2 | 1.39790104 |
36 | PRPF4B | 1.39464075 |
37 | IKBKE | 1.34641309 |
38 | MAP4K1 | 1.33278537 |
39 | IRAK1 | 1.32830888 |
40 | CDK19 | 1.32266629 |
41 | CSNK1G2 | 1.32237987 |
42 | FRK | 1.29189640 |
43 | IKBKB | 1.27143554 |
44 | ZAP70 | 1.24757787 |
45 | MAPKAPK3 | 1.18630966 |
46 | NME1 | 1.17027196 |
47 | CDC7 | 1.17006205 |
48 | MAP4K2 | 1.16681498 |
49 | DAPK1 | 1.15428279 |
50 | ADRBK2 | 1.14392904 |
51 | VRK1 | 1.14352791 |
52 | BMPR2 | 1.14224816 |
53 | MAP3K12 | 1.10159722 |
54 | IRAK2 | 1.06954037 |
55 | SRPK1 | 1.05545540 |
56 | TESK1 | 1.04432007 |
57 | LIMK1 | 1.04291167 |
58 | TBK1 | 1.04053261 |
59 | RIPK4 | 1.02782143 |
60 | TESK2 | 1.01403482 |
61 | SIK3 | 1.01053095 |
62 | CDK8 | 1.00205561 |
63 | AURKA | 0.98883476 |
64 | MAP2K7 | 0.97446888 |
65 | JAK3 | 0.96534473 |
66 | SYK | 0.95489163 |
67 | PRKD2 | 0.93679030 |
68 | TAOK2 | 0.93637245 |
69 | CHEK2 | 0.93331708 |
70 | TYK2 | 0.93247021 |
71 | PLK1 | 0.91361918 |
72 | LYN | 0.89957812 |
73 | BMPR1B | 0.83230062 |
74 | ATR | 0.82928464 |
75 | MAP3K3 | 0.82006051 |
76 | MAPK13 | 0.73016938 |
77 | MAP3K5 | 0.72847335 |
78 | DAPK3 | 0.72834338 |
79 | GRK7 | 0.72247494 |
80 | ZAK | 0.72194473 |
81 | MAPK15 | 0.71595102 |
82 | LCK | 0.71378702 |
83 | KDR | 0.70260989 |
84 | TAOK3 | 0.69442032 |
85 | PLK3 | 0.66839711 |
86 | MST4 | 0.66805365 |
87 | TGFBR2 | 0.65177115 |
88 | TNK2 | 0.64889666 |
89 | MAP2K3 | 0.64146212 |
90 | CAMK1 | 0.63863574 |
91 | PIM1 | 0.63841002 |
92 | NEK1 | 0.63490480 |
93 | PBK | 0.62611633 |
94 | CSK | 0.62518780 |
95 | CSF1R | 0.62328342 |
96 | CDK3 | 0.62222273 |
97 | PRKG2 | 0.62108039 |
98 | CSNK2A1 | 0.61854980 |
99 | WEE1 | 0.61551295 |
100 | HIPK2 | 0.60948759 |
101 | ERN1 | 0.58839887 |
102 | MAP3K11 | 0.57510104 |
103 | TGFBR1 | 0.57459220 |
104 | CSNK1G1 | 0.53435979 |
105 | HCK | 0.53432883 |
106 | BRSK2 | 0.51576983 |
107 | FLT3 | 0.51067899 |
108 | STK38L | 0.50587249 |
109 | PLK4 | 0.50232512 |
110 | GRK1 | 0.49850547 |
111 | EPHA3 | 0.49496236 |
112 | MAP3K13 | 0.49056437 |
113 | RPS6KB2 | 0.49025982 |
114 | CSNK2A2 | 0.48842320 |
115 | MAPKAPK5 | 0.48018462 |
116 | OXSR1 | 0.46826807 |
117 | PAK4 | 0.44816470 |
118 | ATM | 0.43845225 |
119 | TRIM28 | 0.42481524 |
120 | CDK7 | 0.42462989 |
121 | DYRK3 | 0.42178482 |
122 | CSNK1A1 | 0.42017878 |
123 | CAMK1D | 0.41688045 |
124 | SMG1 | 0.40687220 |
125 | MATK | 0.40653118 |
126 | ARAF | 0.40116416 |
127 | MAP2K6 | 0.39954559 |
128 | ITK | 0.39535905 |
129 | AURKB | 0.39465198 |
130 | RPS6KA5 | 0.38188719 |
131 | GRK5 | 0.36948603 |
132 | NEK6 | 0.36549345 |
133 | PIK3CG | 0.35629402 |
134 | MAP3K1 | 0.35581780 |
135 | TIE1 | 0.34814662 |
136 | STK24 | 0.34298507 |
137 | INSRR | 0.34169635 |
138 | TRPM7 | 0.34147572 |
139 | MAPK4 | 0.33933068 |
140 | WNK3 | 0.33228289 |
141 | STK10 | 0.33055063 |
142 | STK39 | 0.32130143 |
143 | BRAF | 0.31972795 |
144 | RPS6KA4 | 0.31074604 |
145 | PINK1 | 0.30818369 |
146 | PRKCD | 0.30292583 |
147 | PAK1 | 0.29840351 |
148 | ILK | 0.29826040 |
149 | EPHA2 | 0.29717111 |
150 | ADRBK1 | 0.29597076 |
151 | ACVR1B | 0.29253360 |
152 | DYRK2 | 0.27311530 |
153 | ABL1 | 0.27197023 |
154 | MOS | 0.26081944 |
155 | RPS6KA6 | 0.25649765 |
156 | CHUK | 0.25498933 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 2.88364117 |
2 | Protein export_Homo sapiens_hsa03060 | 2.83683741 |
3 | DNA replication_Homo sapiens_hsa03030 | 2.60693947 |
4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.51398230 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.39976993 |
6 | Homologous recombination_Homo sapiens_hsa03440 | 2.23758858 |
7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.11302564 |
8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.06299321 |
9 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.05722795 |
10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.97119876 |
11 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.88976992 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.85695496 |
13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.85525053 |
14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.83334552 |
15 | Huntingtons disease_Homo sapiens_hsa05016 | 1.82633665 |
16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.81104003 |
17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.80482888 |
18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.75966158 |
19 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.70825818 |
20 | RNA polymerase_Homo sapiens_hsa03020 | 1.69623326 |
21 | Allograft rejection_Homo sapiens_hsa05330 | 1.68429053 |
22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.63377761 |
23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.62171046 |
24 | Asthma_Homo sapiens_hsa05310 | 1.61331133 |
25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61298319 |
26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.60258401 |
27 | Base excision repair_Homo sapiens_hsa03410 | 1.55228227 |
28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.52906818 |
29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.51466190 |
30 | Measles_Homo sapiens_hsa05162 | 1.50523575 |
31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.50034858 |
32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.47832039 |
33 | Mismatch repair_Homo sapiens_hsa03430 | 1.46619661 |
34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.46100913 |
35 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.45162581 |
36 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.42325827 |
37 | Basal transcription factors_Homo sapiens_hsa03022 | 1.42217273 |
38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40718531 |
39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.40321679 |
40 | Malaria_Homo sapiens_hsa05144 | 1.36835667 |
41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.34681584 |
42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.30439986 |
43 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.28913764 |
44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.28016704 |
45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.27981664 |
46 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.27962703 |
47 | Proteasome_Homo sapiens_hsa03050 | 1.27891852 |
48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.26083196 |
49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.25949384 |
50 | Peroxisome_Homo sapiens_hsa04146 | 1.20595098 |
51 | Pertussis_Homo sapiens_hsa05133 | 1.15774094 |
52 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15334213 |
53 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14941099 |
54 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.10882318 |
55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.10705733 |
56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.10136495 |
57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09042585 |
58 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08066314 |
59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08036765 |
60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.05288044 |
61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.04766725 |
62 | RNA transport_Homo sapiens_hsa03013 | 1.04563720 |
63 | Metabolic pathways_Homo sapiens_hsa01100 | 1.04008274 |
64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03768727 |
65 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.02214071 |
66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.99598592 |
67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.96894930 |
68 | Purine metabolism_Homo sapiens_hsa00230 | 0.96662033 |
69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95891592 |
70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.92478253 |
71 | Tuberculosis_Homo sapiens_hsa05152 | 0.91872944 |
72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.91830339 |
73 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91340391 |
74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.91237554 |
75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.89858025 |
76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88411864 |
77 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88208409 |
78 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.87660844 |
79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86768609 |
80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86759741 |
81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.85657969 |
82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.84762621 |
83 | Spliceosome_Homo sapiens_hsa03040 | 0.84149426 |
84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.80767998 |
85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80760809 |
86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80087602 |
87 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80035887 |
88 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79848088 |
89 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.77925804 |
90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.74744122 |
91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74440354 |
92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.74175178 |
93 | Influenza A_Homo sapiens_hsa05164 | 0.73263749 |
94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71655269 |
95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71067326 |
96 | Lysosome_Homo sapiens_hsa04142 | 0.70679424 |
97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70567113 |
98 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70544087 |
99 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70501200 |
100 | RNA degradation_Homo sapiens_hsa03018 | 0.69712400 |
101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68851317 |
102 | Salmonella infection_Homo sapiens_hsa05132 | 0.66914475 |
103 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66858504 |
104 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66029536 |
105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65930046 |
106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64543475 |
107 | Phagosome_Homo sapiens_hsa04145 | 0.64369980 |
108 | Legionellosis_Homo sapiens_hsa05134 | 0.63721123 |
109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63668244 |
110 | Hepatitis B_Homo sapiens_hsa05161 | 0.63134056 |
111 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.63054277 |
112 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62664292 |
113 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61806947 |
114 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61118650 |
115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60661885 |
116 | Apoptosis_Homo sapiens_hsa04210 | 0.58940092 |
117 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.58324693 |
118 | Carbon metabolism_Homo sapiens_hsa01200 | 0.57541196 |
119 | Shigellosis_Homo sapiens_hsa05131 | 0.57124988 |
120 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56229354 |
121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55505502 |
122 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55324166 |
123 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53811135 |
124 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53796509 |
125 | Phototransduction_Homo sapiens_hsa04744 | 0.53165561 |
126 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52661349 |
127 | Cell cycle_Homo sapiens_hsa04110 | 0.50967754 |
128 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.49750252 |
129 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48898482 |
130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48021454 |
131 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47046335 |
132 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46290035 |
133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.45000970 |
134 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43604090 |
135 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.41963763 |
136 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41598892 |
137 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40903976 |
138 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.39873699 |
139 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.39556704 |
140 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38867445 |
141 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38265485 |
142 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37905273 |
143 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.37877348 |
144 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.36836226 |
145 | Hepatitis C_Homo sapiens_hsa05160 | 0.36580549 |
146 | Mineral absorption_Homo sapiens_hsa04978 | 0.36556901 |
147 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.35682890 |
148 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32403944 |
149 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.31841171 |
150 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.31587015 |
151 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31068097 |
152 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.30696838 |
153 | Parkinsons disease_Homo sapiens_hsa05012 | 0.30320388 |